John E. Gallina - 01 Mar 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & Chief Financial Officer
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 01 Mar 2023
Net transactions value: -$2,455,148
Form type: 4
Filing time: 03 Mar 2023, 15:15:27 UTC
Previous filing: 03 Mar 2022
Next filing: 04 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability	$275,321	-587	-1%	$469.03	55,594	01 Mar 2023	Direct	F1
transaction	ELV	Common Stock	Award	$0	+3,065	+5.5%	$0.000000	58,659	01 Mar 2023	Direct	F2
transaction	ELV	Common Stock	Award	$0	+9,716	+17%	$0.000000	68,375	01 Mar 2023	Direct	F3
transaction	ELV	Common Stock	Tax liability	$2,179,827	-4,650	-6.8%	$468.78	63,725	02 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+11,782		$0.000000	11,782	01 Mar 2023	Common Stock	11,782	$469.03	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows: 1,021 shares on 3/1/2024, and 1,022 shares each on 3/1/2025 and 3/1/2026.
F3	Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
F4	The option represents a right to purchase a total of 11,782 shares, and is exercisable in two installments of 3,927 shares each and one installment of 3,928 shares, beginning on 3/1/2024, which is the one-year anniversary of the option grant date.